Jeff Thomis

Chairman

After a short career in academia, Dr. Jeff Thomis spent 35 years in the clinical and commercial development of new medicines. For the first 20 years, he was at Bristol-Myers Squibb. For the next 15 years, he was at Quintiles, where he was President of Clinical Development Services and Chairman of the American Management Board. Since then he has held a number of Board positions including Non-Executive Chairman at Idis. He currently is Non-Executive Chairman of Quotient Sciences, sits on the board of Cesca Therapeutics , a market leader in cell based therapies, and NovaQuest, a US-based Health Care PE company. He is also a Senior Advisor to GHO Capital, a Health Care PE company.

Jaswinder Khera

Managing Director US

At WEP Clinical, Jaswinder oversees the growth and strategy of the business in the Americas. Jaswinder brings over 30 years of experience in the pharmaceutical Industry in senior sales and marketing positions with Sanofi, MSD and Astra. He also held senior management positions in operations and business development during his 10 years with Quintiles.

Jaswant Khera

Managing Director UK

Following sales and management experience with Pfizer, where he led a team that marketed the global blockbusters Lipitor & Neurontin, Jaswant went on to launch WE Pharma, now called WEP Clinical. He brings with him 20 years of commercial, strategic, operational and marketing experience as well as a deep understanding of international markets and commercialization of drugs. Currently serving as Managing Director EU, he is responsible for the growth and strategy of the business.

jULIAN PHIPPS

Chief Financial Officer

Julian brings over 25 years experience of senior financial roles in various groups including Capita, SunGard and Northgate. Julian was the group auditor of Ciba-Geigy in the five years leading up to the merger with Sandoz that created Novartis. Julian also brings significant experience of mergers and acquisitions to the WEP Clinical team.

BRIAN HOOD

Head of Operations

With over 25 years experience in managing complex and regulated global supply chains, Brian heads up our logistical and quality operations in the EU. Previous experiences include 3PL management, project management, client and vendor relationship management and lean process improvement systems. Prior to joining WEP, Brian spent several years at Idis and Clinigen managing global distribution and secondary packaging production networks in the UK, EU, Asia and North America.

MATT COMSTOCK

VP Business Development (CTS)

Matt has nearly two decades of experience working in the pharmaceutical and CRO space. He worked previously in data management and finance at Quintiles for nearly 15 years and also has experience in research, strategic account management, sales and relationship development. As the VP Business Development (CTS) at WEP Clinical, Matt is responsible for developing new customer accounts as well as growing relationships with existing customers.

MATT COMSTOCK

Vice President, Business Development

Matt has nearly two decades of experience working in the pharmaceutical and CRO space. He worked previously in data management and finance at Quintiles for nearly 15 years and also has experience in research, strategic account management, sales and relationship development. As the Business Development Director at WEP Clinical, Matt is responsible for developing new customer accounts as well as growing relationships with existing customers.

ENTRANE HARVEY

Head of Project Management

Entrane has been in the pharmaceutical and CRO industry for over 27 years with extensive experience in clinical operations and global project management. He joined WEP Clinical in 2017, after working at Glaxo SmithKline. In his current role, Entrane is responsible for the growth of Expanded Access Clinical and Project Management Operations. His approach to solid project management systems and processes drives value and superior quality for our clients.

ENTRANE HARVEY

Head of Project Management

Entrane has been in the Pharmaceutical and CRO industry for over twenty-seven years with extensive experience in Clinical Operations and Global Project Management. He joined WEP Clinical in 2017 after working at Glaxo SmithKline. In his current role, Entrane is responsible for the growth of Expanded Access Clinical and Project Management Operations. His approach to solid project management systems and processes drives value and superior quality for our clients.

Tracey harden

Senior Quality Manager US

Tracey has nearly 15 years of experience working in the pharmaceutical and CRO space. She has extensive experience in Quality Assurance across the GxPs. She recently joined WEP Clinical after working at RTI International. As the Senior Quality Manager, Tracey is responsible for the quality oversight of all Expanded Access Clinical project work as well as Sourcing and Wearhouse Distribution activities. Tracey also ensures that all internal quality processes are held to the highest standards.

Antoine Doyen

Senior Quality Manager EU

As the Quality Manager for our EU team, Antoine uses his expertise to maintain a robust Quality Management System in order to assure patient safety and product quality whilst delivering outstanding service to customers and clients. Previously, Antoine worked at Clinigen and Idis, where he developed extensive knowledge and experience in distribution and secondary packaging of licensed, unlicensed and clinical trial medicines. Antoine has strong experience at implementing and developing all elements of a Quality Management System, and is a keen advocate of continuous improvement methodologies.

SARAH MASON

Senior Regulatory Manager

Sarah joined WEP Clinical in 2019 bringing with her over 15 years’ experience of working in the pharmaceutical industry, specifically the regulations and supply mechanisms around unlicensed medicines. Prior to joining WEP Sarah worked for IDIS, where she was instrumental in establishing and growing the regulatory function, supporting both operational and strategic business activities. She went on to work for Clinigen, managing the regulatory functions across the group.

chris barnett

Regulatory Affairs

Experience in the principles of International Quality Assurance and project and line management gained in various tenures at the Wellcome Foundation Limited, Glaxo Wellcome and Glaxo SmithKline, led Chris to his certification as an EU Qualified Person (QP) with particular expertise in clinical trial materials. His forty years of experience enables him to provide expert knowledge of the principles and regulation of Good Manufacturing Practice (GMP), Good Distribution Practice (GDP) and Quality Assurance.